RET and medullary thyroid gland carcinoma: The presence of a considerable amount of hereditary tumors among our patients, in addition to the presence of germ-line RET mutations in up to 14.9% of patients with sporadic MTC [13], confirmed the need for a routine genetic screening as recommended by ATA guidelines.